(7S)-7-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrobromide

Compound number
MolPort-003-941-604
CAS number
76135-31-4; 78095-20-2
IUPAC
(7S)-7-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrobromide
IUPAC traditional
(7S)-7-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrobromide
SMILES
Br.CCCN(CCC)[C@H]1CCc2cccc(O)c2C1 |r|
InChI key
BATPBOZTBNNDLN-UQKRIMTDSA-N
Molecular formula
Molecular weight
328.294
Solubility
not available

Warning!
This substance is controlled or otherwise illegal in the following legislations. Please make certain that it is acceptable for import into your Order's intended destination country.

Compliance Information

Ireland IE MISUSE OF DRUGS REGULATIONS 1988 Schedule I

Marketplace Offers

Axon Medchem

Direct S&H to USA 40.00 USD Direct S&H to World: 60.00 USD
Catalog
Screening compound
Ships out
2 business days
Purity
98.00
Last updated
3 months ago
In warehouse
Unverified

Supplier Catalogue Data

Pack size Ships out Price Quantity
10 mg May 24, 2022 148.35 USD
Add to Cart Buy
50 mg May 24, 2022 593.40 USD
Add to Cart Buy

More Information

Compound identifiers

Compound number
MolPort-003-941-604
CAS number
76135-31-4; 78095-20-2

Names, Synonyms and 3rd Party Identifiers

Name
(S)-(-)-8-Hydroxy-DPAT hydrobromide
(S)-7-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-1-ol hydrobromide
DPAT, (S)-(-)-8-OH-
S(-)-8-Hydroxy-DPAT hydrobromide

InChI

InChI
1/C16H25NO.BrH/c1-3-10-17(11-4-2)14-9-8-13-6-5-7-16(18)15(13)12-14;/h5-7,14,18H,3-4,8-12H2,1-2H3;1H/t14-;/m0./s1
InChI key
BATPBOZTBNNDLN-UQKRIMTDSA-N

Formula

Molecular formula
C16H26BrNO
Molecular weight
328.294

MolPort Guarantee

When you purchase products through the MolPort website from any seller other than MolPort itself, you will be protected by the MolPort Guarantee. If you purchase products from MolPort itself, this MolPort Guarantee will not apply, and your remedies will be governed by the MolPort Terms of Sale and Supply.

Copyright 2022 MolPort. All rights reserved. v5.96

We use cookies to improve your experience on our websites and for advertising. Learn more Accept

Feedback